#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	7174	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2606	774.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1588	1588	C	898	C,A,G	720,2,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	7174	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2606	774.2	0	HET	.	.	.	T454TG	.	454	454	T	858	858	T	1063	TG,T	611,222	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	11884	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4166	809.7	0	.	n	.	0	T695C	SNP	695	695	T	1291	1291	C	849	C,T,G	519,174,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	11884	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4166	809.7	0	.	n	.	0	G1337A	SNP	1337	1337	G	1933	1933	A	1029	A,C	846,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	11884	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4166	809.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2567	2567	C	999	C,T,A	821,2,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	11884	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4166	809.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2641	2641	A	1045	A	848	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	11884	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4166	809.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	3193	3193	C	986	C,A	809,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_N_01367c	folP.WHO_N_01367c	1	1	27	972	folP	852	852	100.0	folP.l15.c4.ctg.1	1935	143.3	1	SNP	p	R228S	1	.	.	682	684	AGC	1200	1202	AGC	180;180;179	A;G;C	141;143;137	folP.WHO_N_01367c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	27	2384	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3833	176.4	1	SNP	p	S91F	1	.	.	271	273	TTC	747	749	TTC	195;195;195	T;T;C	160;164;162	gyrA.WHO_G_01105:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	27	2384	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3833	176.4	1	SNP	p	D95G	0	.	.	283	285	GAC	759	761	GAC	195;194;194	G,C;A,C;C	156,1;149,1;148	gyrA.WHO_G_01105:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	27	2384	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3833	176.4	1	SNP	p	D95N	0	.	.	283	285	GAC	759	761	GAC	195;194;194	G,C;A,C;C	156,1;149,1;148	gyrA.WHO_G_01105:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_M_01390	mtrR.WHO_M_01390	1	1	27	1048	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1912	157.5	1	SNP	p	G45D	1	.	.	133	135	GAC	742	744	GAC	286;286;288	G,T;A,C,T;C	225,1;223,4,1;233	mtrR.WHO_M_01390:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	690	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1408	142.0	0	.	n	.	0	A197.	DEL	197	197	A	764	764	A	297	A,C	248,1	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	2226	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3403	187.0	0	.	p	.	0	R262_V263insG	INS	784	784	C	1352	1352	G	214	G	178	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	2226	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3403	187.0	1	SNP	p	D86N	0	.	.	256	258	GAC	823	825	GAC	229;225;225	G,C;A,C;C	180,1;172,1;173	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	2226	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3403	187.0	1	SNP	p	S88P	0	.	.	262	264	TCC	829	831	TCC	228;229;230	T;C;C,A	178;185;181,1	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1952	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3117	179.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1732	1734	GGC	248;245;244	G;G,T;C,G	210;209,1;188,2	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.10.001	penA.10.001	1	1	27	1950	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2955	188.6	1	SNP	p	A311V	0	.	.	931	933	GCC	1573	1575	GCC	246;249;249	G;C;C	201;204;203	penA.10.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	1950	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2955	188.6	1	SNP	p	I312M	1	.	.	934	936	ATG	1576	1578	ATG	249;249;250	A;T;G	209;205;205	penA.10.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	1950	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2955	188.6	1	SNP	p	V316T	1	.	.	946	948	ACC	1588	1590	ACC	252;252;251	A,C;C;C	206,1;200;208	penA.10.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	1950	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2955	188.6	1	SNP	p	T316P	0	.	.	946	948	ACC	1588	1590	ACC	252;252;251	A,C;C;C	206,1;200;208	penA.10.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	1950	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2955	188.6	1	SNP	p	T483S	0	.	.	1447	1449	ACC	2089	2091	ACC	247;247;245	A;C,A;C	201;201,2;206	penA.10.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	1950	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2955	188.6	1	SNP	p	A501V	0	.	.	1501	1503	GCG	2143	2145	GCG	245;247;251	G,C;C;G	200,1;192;197	penA.10.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	1950	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2955	188.6	1	SNP	p	A501P	0	.	.	1501	1503	GCG	2143	2145	GCG	245;247;251	G,C;C;G	200,1;192;197	penA.10.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	1950	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2955	188.6	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2266	2268	GGT	230;230;232	G;G;T,G	189;191;193,1	penA.10.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	1950	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2955	188.6	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2275	2277	AGC	231;229;230	A;G;C	189;193;190	penA.10.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	1950	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2955	188.6	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2293	2295	CCG	234;235;236	C;C;G,C	195;197;200,1	penA.10.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	2450	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	3471	201.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1778	1780	CCG	177;178;178	C;C,G;G,A,C	147;142,1;140,1,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1082	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2289	135.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	793	793	C	156	C,G	120,1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	196	porB1a	984	287	90.38	porB1a.l15.c4.ctg.1	1587	35.3	0	.	p	.	0	H217N	NONSYN	649	651	CAT	1325	1327	AAT	5;5;5	A;A;T	5;5;5	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	196	porB1a	984	287	90.38	porB1a.l15.c4.ctg.1	1587	35.3	0	.	p	.	0	D218N	NONSYN	652	654	GAT	1328	1330	AAT	5;5;5	A;A;T	5;5;5	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	196	porB1a	984	287	90.38	porB1a.l15.c4.ctg.1	1587	35.3	0	.	p	.	0	A222V	NONSYN	664	666	GCT	1340	1342	GTT	3;3;3	G;T;T	3;3;3	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	196	porB1a	984	287	90.38	porB1a.l15.c4.ctg.1	1587	35.3	0	.	p	.	0	V226A	NONSYN	676	678	GTA	1352	1354	GCA	3;3;3	G;C;A	3;3;3	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	196	porB1a	984	287	90.38	porB1a.l15.c4.ctg.1	1587	35.3	0	.	p	.	0	.	MULTIPLE	700	702	ACT	1375	1377	GTA	2;2;2	G;T;A	2;2;2	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	196	porB1a	984	287	90.38	porB1a.l15.c4.ctg.1	1587	35.3	0	.	p	.	0	N237fs	FSHIFT	709	709	A	1384	1384	A	2	A	2	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1398	porB1b	1038	1038	96.59	porB1b.l15.c4.ctg.1	2101	189.1	0	.	p	.	0	I45V	NONSYN	133	135	ATT	659	661	GTT	280;280;283	G;T;T,G	230;232;231,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1398	porB1b	1038	1038	96.59	porB1b.l15.c4.ctg.1	2101	189.1	0	.	p	.	0	N189G	NONSYN	565	567	AAC	1091	1093	GGC	247;246;246	G;G,T;C,A	205;207,1;205,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1398	porB1b	1038	1038	96.59	porB1b.l15.c4.ctg.1	2101	189.1	0	.	p	.	0	K207_M208insK	INS	619	619	A	1145	1145	A	244	A	199	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1398	porB1b	1038	1038	96.59	porB1b.l15.c4.ctg.1	2101	189.1	0	.	p	.	0	M208I	NONSYN	622	624	ATG	1151	1153	ATC	237;235;232	A;T,G;C	201;196,1;194	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1398	porB1b	1038	1038	96.59	porB1b.l15.c4.ctg.1	2101	189.1	0	.	p	.	0	E209_G210insY	INS	625	625	G	1154	1154	G	234	G	200	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1398	porB1b	1038	1038	96.59	porB1b.l15.c4.ctg.1	2101	189.1	0	.	p	.	0	G210fs	FSHIFT	628	628	G	1161	1161	A	233	A,G	188,2	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1398	porB1b	1038	1038	96.59	porB1b.l15.c4.ctg.1	2101	189.1	1	SNP	p	G120K	1	.	.	358	360	AAG	884	886	AAG	296;295;294	A;A;G	228;230;224	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1398	porB1b	1038	1038	96.59	porB1b.l15.c4.ctg.1	2101	189.1	1	SNP	p	A121N	1	.	.	361	363	AAC	887	889	AAC	294;294;293	A;A,C;C	230;230,1;225	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1398	porB1b	1038	1038	96.59	porB1b.l15.c4.ctg.1	2101	189.1	1	SNP	p	N121D	0	.	.	361	363	AAC	887	889	AAC	294;294;293	A;A,C;C	230;230,1;225	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	4440	rpoB	4179	4179	99.98	rpoB.l6.c4.ctg.1	5306	237.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	764	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1526	145.8	1	SNP	p	V57M	1	.	.	169	171	ATG	733	735	ATG	295;296;296	A,C;T;G,T	244,1;245;242,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
